Suppression of Very Early Stage Of Adipogenesis by Baicalein, a Plant-Derived Flavonoid through Reduced Akt-C/EBPα-GLUT4 Signaling-Mediated Glucose Uptake in 3T3-L1 Adipocytes.
Baicalein has been used as a Chinese medicine, and is an abundant plant flavonoid present in fruits and vegetables. Here, we examined the effects of baicalein in adipogenesis and investigated its molecular mechanism in adipocytes. Baicalein lowered the intracellular lipid accumulation and decreased the transcription levels of the adipocyte-specific genes in mouse 3T3-L1 adipocytes. Glucose uptake mediated by glucose transporter 4 (GLUT4) was reduced, causing down-regulation of the intracellular lipid accumulation. These reductions were also observed even when baicalein was added in only early stage of adipogenesis (0-2 days) of 6-day-adipogenesis. Chromatin immunoprecipitation assay showed that baicalein decreased the binding level of C/EBPα protein to the promoter region of the GLUT4 gene. Phosphorylation of Akt at 1 h after the initiation of adipogenesis was inhibited by the treatment with baicalein. Inhibition during only the first 1.5 h after the initiation of adipogenesis by baicalein or an Akt inhibitor was enough to decrease the lipid contents in the cells undergoing adipocyte differentiation for 6 days. These results indicate that baicalein decreased the intracellular lipid accumulation by down-regulation of glucose uptake via repression of Akt-C/EBPα-GLUT4 signaling in the very early stage of adipogenesis of 3T3-L1 adipocytes.
Laboratory of Biodefense and Regulation, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
Yukari
Y
Nakao
Laboratory of Biodefense and Regulation, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
Hideto
H
Yoshihara
Laboratory of Biodefense and Regulation, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
Ko
http://orcid.org/0000-0002-2506-0769
K
Fujimori
Am J Clin Nutr. 2001 Oct;74(4):418-25
11566638
Front Pharmacol. 2014 Jan 10;4:177
24454289
Prostaglandins Leukot Essent Fatty Acids. 2005 Jul;73(1):31-4
15936931
Endocrinology. 2006 May;147(5):2245-52
16497797
Annu Rev Public Health. 2001;22:355-75
11274526
Biochem J. 2014 May 1;459(3):489-503
24511897
J Nutr Biochem. 2013 Nov;24(11):1777-89
24029069
Life Sci. 1999;65(4):337-53
10421421
PLoS One. 2009 Jul 10;4(7):e6189
19593385
Trends Endocrinol Metab. 2009 Apr;20(3):107-14
19269847
J Biochem. 2012 Apr;151(4):447-55
22418579
Vitam Horm. 2009;80:245-86
19251041
Int J Oncol. 2007 Jan;30(1):233-45
17143534
J Nutr Biochem. 2011 Oct;22(10):910-20
21189228
J Agric Food Chem. 2015 May 27;63(20):4979-87
25945786
Mol Cancer Ther. 2006 Apr;5(4):843-52
16648554
J Nutr Biochem. 2014 Jan;25(1):1-18
24314860
Food Chem Toxicol. 2014 May;67:57-64
24560969
FEBS Lett. 2010 Aug 4;584(15):3242-9
20542036
FEBS Lett. 2006 Oct 16;580(24):5765-71
17022980
World J Gastroenterol. 2012 Dec 14;18(46):6771-81
23239915
Food Chem Toxicol. 2004 May;42(5):803-7
15046826
Cardiovasc Hematol Agents Med Chem. 2011 Apr 1;9(2):62-77
21644918
BMC Complement Altern Med. 2012 Apr 03;12 :31
22471389
J Biol Chem. 2004 Aug 20;279(34):35914-22
15192111
J Med Food. 2006 Summer;9(2):145-53
16822198
J Nutr. 2009 Jan;139(1):51-7
19056650
J Agric Food Chem. 2013 May 29;61(21):5139-47
23647459
Cell. 2007 Jun 29;129(7):1261-74
17604717
Genes Dev. 2000 Jun 1;14(11):1293-307
10837022
Pharmacol Ther. 2001 May-Jun;90(2-3):157-77
11578656
Diabetes Metab Res Rev. 2002 Sep-Oct;18(5):345-56
12397577
Drug Saf. 2008;31(5):416-8
18422382
Mol Endocrinol. 2007 May;21(5):1120-31
17312274
Proc Natl Acad Sci U S A. 1990 Jan;87(1):251-5
2404278
Annu Rev Biochem. 2008;77:289-312
18518822
Diabetes Metab Syndr Obes. 2014 Feb 13;7:55-64
24611020
Biofactors. 2010 Nov-Dec;36(6):415-22
20803522